Everolimus 10 mg Tablets UK

Services Faridabad 6 views Reference: 91937

Location: Faridabad

Price: Contact us

are prescription-only tablets used to treat advanced kidney cancer, hormone receptor-positive breast cancer, and neuroendocrine tumors. They are also prescribed for preventing organ transplant rejection. As an mTOR inhibitor, Everolimus helps slow abnormal cell growth and reduces immune responses for better transplant outcomes.

Everolimus Tablets 10 mg offer targeted treatment for advanced cancers and immunosuppressive therapy to prevent organ rejection in transplant patients. This prescription-only medicine belongs to the class of mTOR inhibitors, which interfere with cellular activity involved in growth, replication, and immune function.

Primarily used in oncology and transplant care, Everolimus is prescribed by specialists to manage several life-threatening conditions. The 10 mg dosage strength is generally recommended for adults under detailed treatment plans and monitoring.

What is Everolimus 10 mg Used For?

Everolimus 10 mg tablets are indicated in the treatment of:

Renal Cell Carcinoma (Advanced kidney cancer)
Hormone Receptor-positive, HER2-negative Breast Cancer
Pancreatic Neuroendocrine Tumors (pNET)
Subependymal Giant Cell Astrocytoma (SEGA) in patients with Tuberous Sclerosis
Prophylaxis of organ rejection in liver and kidney transplant recipients

This drug is often used in combination with other therapies such as hormonal agents (e.g., exemestane) or as part of multi-drug transplant protocol.

How Does Everolimus Work?

Everolimus functions as a selective mTOR inhibitor, disrupting a critical cell signaling pathway that controls:

Cell replication and proliferation
Angiogenesis (formation of new blood vessels)
Immune system regulation

By targeting this pathway, Everolimus:

Inhibits cancer cell division and tumor growth
Reduces the nutrient supply to tumors
Suppresses overactive immune responses to prevent organ rejection

Its targeted mechanism offers an alternative to traditional chemotherapy with more selective effects and improved tolerability for long-term treatment.